Form 4 holding
Director
Oncology Institute, Inc.
- Security class
- Common Stock
- Shares / value
- 5,444,207
- Estimated value
- $25,097,794
- Report date
- 18 Nov 2025
- Price
- $4.61
- Ownership
- Direct
M33 Growth I L.P. - Director at Starling Oncology, Inc.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- STLN, STLNW on Nasdaq, TOI, DFPH on OTC
- Entity type
- Company
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by M33 Growth I L.P. since 17 Sep 2025
Reported holdings for M33 Growth I L.P. in Starling Oncology, Inc.
Form 4 holding
Director
Oncology Institute, Inc.
- Security class
- Warrant to Purchase Shares of Common Stock
- Shares / value
- 1,358,449
- Estimated value
- $169,806
- Report date
- 26 Mar 2025
- Price
- $0.1250
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Form 4 holding
Director
Oncology Institute, Inc.
- Security class
- Common Stock
- Shares / value
- 0
- Estimated value
- $0
- Report date
- 18 Nov 2025
- Price
- $4.61
- Ownership
- Indirect
Transaction history for M33 Growth I L.P. in Starling Oncology, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.